4
Changes in Ownership
BIOMARIN PHARMACEUTICAL INC Filed Acc 0001209191-23-023942
Chief Executive Officer sold 10,000 shares at $96.13 ($961,300)
- Chief Executive Officer acquired 10,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
BIENAIME JEAN JACQUES · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-04-06 | Exercise or conversion : show line 1 in the form 10b5-1 | +10,000 | $67.81 | $678,100 | 435,896 | D |
| 2023-04-06 | Sale : show line 2 in the form 10b5-1 | −10,000 | $96.13 | $961,300 | 425,896 | D |
| Open-market sales · 10,000 sh · avg $96.13 · $961,300 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-04-06 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy Common Stock) | −10,000 | 139,130 | D |
Loading xslF345X04/doc4.xml…